Australia's prescription drug monitoring programs need to look out for unintended harms

Publicly released:
Australia; VIC
Photo by Patrick Tomasso on Unsplash
Photo by Patrick Tomasso on Unsplash

Prescription drug monitoring programs (PDMP), which monitor the prescribing and dispensing of controlled medicines including opioids, may be having unintended negative consequences and must be closely evaluated, according to Australian experts. Several US studies suggest that restricting access to opioids via PDMPs caused patients to seek illicit drugs and heroin-related deaths in the US rose after the monitoring programs were introduced. The researchers say Australia must evaluate these programs to ensure we don't see similar negative impacts here, with early signs of possible unintended consequences already being observed in Victoria.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Wiley, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference:
Drug and Alcohol Review
Research:Paper
Organisation/s: Monash University, The University of New South Wales
Funder: LP is the recipient of the National Health and Medical Research Council Investigator Grant (#2016909). AR is the recipient of the National Health and Medical Research Council Investigator Grant (#2016695).
Media Contact/s
Contact details are only visible to registered journalists.